On the other hand, several researchers have reported that females were less likely to respond to anti-TNF treatment and were more likely to discontinue anti-TNF treatment early based on data from registries of rheumatic disease including AS [24–29]. The gene discussed is TNF; the disease is rheumatic disorder.